Harvard Bioscience Inc. (HBIO)

Harvard Bioscience Inc. Azioni (HBIO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	11.00% 28.15	25.36	28.76	29.98	28.43
Cost Of Revenue	11.21% 11.83	10.64	12.09	11.63	12.59
Gross Profit	10.85% 16.32	14.73	16.67	18.35	15.83
Operating Expenses	2.45% 16.04	15.66	15.88	16.60	16.29
Benefits Costs and Expenses	12.85% 29.26	25.93	30.86	28.77	29.32
Costs And Expenses	12.85% 29.26	25.93	30.86	28.77	29.32
Operating Income/Loss	130.23% 0.282	-0.933	0.796	1.749	-0.457
Nonoperating Income/Loss	473.32% -1.385	0.371	-2.894	-0.542	-0.435
Income/Loss From Continuing Operations Before Tax	96.26% -1.103	-0.562	-2.098	1.207	-0.892
Income Tax Expense/Benefit	5.61% 0.715	0.677	-1.118	0.585	0.774
Income/Loss From Continuing Operations After Tax	46.73% -1.818	-1.239	-0.98	0.622	-1.666
Net Income/Loss	46.73% -1.818	-1.239	-0.98	0.622	-1.666
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.82% 0.075	42.69	42.35	42.12	0.06
Diluted Average Shares	99.82% 0.075	42.69	42.35	42.78	0.06
Basic Earnings Per Share	33.33% -0.04	-0.03	-0.02	0.01	-0.04
Diluted Earnings Per Share	33.33% -0.04	-0.03	-0.02	0.01	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-